DelveInsight Business Research LLP

DelveInsight’s “Pleural Effusion Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pleural Effusion, historical and forecasted epidemiology as well as the Pleural Effusion market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Pleural Effusion market report provides current treatment practices, emerging drugs, Pleural Effusion market share of the individual therapies, and current and forecasted Pleural Effusion market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Pleural Effusion treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Pleural Effusion market.

 Pleural Effusion Overview

This is the thin tissue that lines the chest cavity and surrounds the lungs. Pleural effusion is an abnormal, excessive collection of this fluid. There are two types of pleural effusion: Transudative pleural effusion is caused by fluid leaking into the pleural space.

Pleural Effusion Epidemiology Insights:

• In the United States, up to one million patients develop parapneumonic effusions annually, and approximately 100,000 patients undergo pleurodesis for recurrent pleural effusions per year. Pleural effusion is reported to have an incidence of 0.32% in a study among the general population in central Bohemia. Congestive heart failure accounts for nearly 50% of cases, with malignancy, pneumonia and pulmonary emboli as the next three leading causes.] However, the distribution of causes is largely dependent on the population studied.

• The incidence of pleural effusion among ICU patients is estimated to be 22.19 ± 17%.

• Tuberculosis is one of the most frequent causes of pleural effusion. Although, the incidence has steadily declined in some countries (4.8 cases/100,000 population), the prevalence of tuberculous pleural effusion remains steady with respect to the total number of TB cases (14.3%-19.3%).

• The incidence of parapneumonic effusions is constantly increasing, although, the microbial epidemiology of these effusions differs from pneumonia with a higher prevalence of anaerobic bacteria.

• The incidence of pediatric empyema increased from 1 per 100,000 children aged 0 to 14 years in 1998 to 10 per 100,000 in 2012, with a peak incidence of 13 per 100,000 in 2009 with Staphylococcus aureus as the most frequent cause followed by S. pneumoniae.

Pleural Effusion Epidemiology Segmentation

• Total Pleural Effusion prevalent cases 
• Total  Pleural Effusion incident cases 
• Total Pleural Effusion diagnostic cases 
• Total Pleural Effusion treatment cases 

Pleural Effusion Market Outlook 

The Pleural Effusions market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Pleural Effusions market trends by analyzing the impact of current Pleural Effusions therapies on the market, unmet needs, drivers and barriers, and demand for better technology.  This segment gives a thorough detail of the Pleural Effusions market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Pleural Effusions market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Pleural Effusions market in 7MM is expected to witness a major change in the study period 2019-2032.

Learn more by requesting for sample @ Pleural Effusion Market Trends

Pleural Effusion Key Companies

• Lung Therapeutics 
• Carefusion 
• Pfizer 
• Roche 

And many others 

Pleural Effusion Key Therapy 

• Abnoba Viscum F 20mg
• ENDOSTAR
• LTI-01
• SCB-313

And many others 

 Table of Contents

1.  Key Insights 
2.  Report Introduction 
3.  Executive Summary of Pleural Effusion
4.  Disease Background and Overview
5.  Epidemiology and patient population
6.  The United States 
7.  EU 5
8.  Pleural Effusion Emerging Therapies
9.  Pleural Effusion Market Outlook
10.  Market Access and Reimbursement of Therapies
11.  Market Drivers 
12.  Market Barriers 
13.  Appendix
14.  Pleural Effusion Report Methodology
15.  DelveInsight Capabilities
16.  Disclaimer

Click here to read more about Pleural Effusion Market Trends

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services